The Journal of Organic Chemistry
Article
7.6, 1.7 Hz, 1H), 7.40 (dd, J = 7.8, 1.4 Hz, 1H), 7.32−7.22 (m, 2H),
5.86 (ddt, J = 16.1, 10.8, 5.5 Hz, 1H), 5.28−5.16 (m, 2H), 4.74 (s,
1H), 4.68−4.56 (m, 2H), 2.70 (dt, J = 10.5, 5.3 Hz, 2H), 2.59−2.50
(m, 2H), 1.90−1.76 (m, 4H). 13C{1H} NMR (101 MHz, CDCl3) δ
170.7, 134.8, 133.9, 131.7, 130.1, 129.5, 129.1, 127.1, 118.1, 67.9,
65.4, 52.1 (2C), 23.3 (2C). HRMS (ESI-TOF) m/z: [M + H+] calcd
for C15H19ClNO2 280.1099, found 280.1106.
2.56 (dt, J = 6.0, 3.2 Hz, 2H), 2.48−2.41 (m, 2H), 1.82 (td, J = 5.7,
3.1 Hz, 4H). 13C{1H} NMR (101 MHz, CDCl3) δ 171.8, 136.4, 131.7
(2C), 130.1 (2C), 122.3, 73.2, 52.5 (2C), 52.2, 23.3 (2C). HRMS
(ESI-TOF) m/z: [M + H+] calcd for C13H17BrNO2 298.0437, found
298.0424.
Methyl 2-(Pyrrolidin-1-yl)-2-(4-(tosyloxy)phenyl)acetate ( 17).
Purification with petroleum ether/EtOAc (8:2) as the eluent;
1
Benzo[d][1,3]dioxol-5-ylmethyl-2-(2-chlorophenyl)-2-(pyrrolidin-
colorless liquid (304 mg, 78% yield). H NMR (400 MHz, CDCl3)
1-yl)acetate ( 10). Purification with petroleum ether/EtOAc (8:2)
δ 7.73 (d, J = 8.4 Hz, 2H), 7.42 (d, J = 8.6 Hz, 2H), 7.32 (d, J = 8.0
Hz, 2H), 6.98 (d, J = 8.7 Hz, 2H), 3.92 (s, 1H), 3.70 (s, 3H), 2.57−
2.50 (m, 2H), 2.47 (s, 3H), 2.44−2.37 (m, 2H), 1.81 (td, J = 10.2,
8.5, 5.3 Hz, 4H). 13C{1H} NMR (101 MHz, CDCl3) δ 171.7, 149.5,
145.4, 136.2, 132.5, 129.8 (2C), 129.7 (2C), 128.5 (2C), 122.5 (2C),
73.0, 52.5 (2C), 52.3, 23.3 (2C), 21.7. HRMS (ESI-TOF) m/z: [M +
H+] calcd for C20H24NO5S 390.1370, found 390.1377.
Ethyl 2-Phenyl-2-(pyrrolidin-1-yl)acetate ( 18). Purification with
petroleum ether/EtOAc (9:1) as the eluent; colorless liquid (180 mg,
77% yield). 1H NMR (400 MHz, CDCl3) δ 7.46 (dt, J = 8.4, 2.2 Hz,
2H), 7.34−7.27 (m, 3H), 4.22−4.06 (m, 2H), 3.89 (s, 1H), 2.55 (td,
J = 7.1, 2.4 Hz, 2H), 2.47−2.38 (m, 2H), 1.83−1.73 (m, 4H), 1.18 (t,
J = 7.1 Hz, 3H). 13C{1H} NMR (101 MHz, CDCl3) δ 171.6, 137.4,
128.4 (2C), 128.3 (2C), 128.1, 73.9, 60.8, 52.4 (2C), 23.3 (2C), 14.0.
HRMS (ESI-TOF) m/z: [M + H+] calcd for C14H20NO2 234.1489,
found 234.1486.
Ethyl 2-(4-Chlorophenyl)-2-(pyrrolidin-1-yl)acetate ( 19). Purifi-
cation with petroleum ether/EtOAc (9:1) as the eluent; colorless
liquid (212 mg, 79% yield). 1H NMR (400 MHz, CDCl3) δ 7.44 (d, J
= 8.4 Hz, 2H), 7.32 (d, J = 8.5 Hz, 2H), 4.21−4.09 (m, 2H), 3.89 (s,
1H), 2.56 (ddd, J = 8.7, 7.4, 4.2 Hz, 2H), 2.44 (ddd, J = 9.7, 7.7, 4.3
Hz, 2H), 1.81 (td, J = 5.8, 3.1 Hz, 4H), 1.21 (t, J = 7.1 Hz, 3H).
13C{1H} NMR (101 MHz, CDCl3) δ 171.4, 136.1, 134.0, 129.7 (2C),
128.7 (2C), 73.3, 61.1, 52.4 (2C), 23.3 (2C), 14.1. HRMS (ESI-
TOF) m/z: [M + H+] calcd for C14H19ClNO2 268.1099, found
268.1096.
Ethyl 2-(4-Bromophenyl)-2-(pyrrolidin-1-yl)acetate ( 20). Purifi-
cation with petroleum ether/EtOAc (9:1) as the eluent; colorless
liquid (240 mg, 77% yield). 1H NMR (400 MHz, CDCl3) δ 7.44 (d, J
= 8.5 Hz, 2H), 7.34 (d, J = 8.5 Hz, 2H), 4.20−4.05 (m, 2H), 3.84 (s,
1H), 2.52 (td, J = 7.1, 2.4 Hz, 2H), 2.45−2.37 (m, 2H), 1.82−1.73
(m, 4H), 1.17 (t, J = 7.1 Hz, 3H). 13C{1H} NMR (101 MHz, CDCl3)
δ 171.2, 136.5, 131.6 (2C), 130.0 (2C), 122.1, 73.2, 61.0, 52.4 (2C),
23.3 (2C), 14.0. HRMS (ESI-TOF) m/z: [M + H+] calcd for
C14H19BrNO2 312.0594, found 312.0571.
1
as the eluent; colorless liquid (254 mg, 68% yield). H NMR (400
MHz, CDCl3) δ 7.68 (dd, J = 7.5, 2.0 Hz, 1H), 7.36 (dd, J = 7.5, 1.8
Hz, 1H), 7.28−7.18 (m, 2H), 6.72 (s, 3H), 5.92 (s, 2H), 5.09−4.98
(m, 2H), 4.71 (s, 1H), 2.63 (td, J = 7.1, 2.3 Hz, 2H), 2.53−2.45 (m,
2H), 1.79 (dt, J = 6.0, 3.0 Hz, 4H). 13C{1H} NMR (101 MHz,
CDCl3) δ 170.9, 147.5, 147.3, 134.7, 133.8, 130.0, 129.4, 129.3, 129.0,
126.9, 121.8, 108.6, 107.9, 100.9, 67.8, 66.4, 51.9 (2C), 23.3 (2C).
HRMS (ESI-TOF) m/z: [M + H+] calcd for C20H21ClNO4 374.1154,
found 374.1158.
Benzyl 2-(2-Chlorophenyl)-2-(pyrrolidin-1-yl)acetate ( 11). Pu-
rification with petroleum ether/EtOAc (8:2) as the eluent; colorless
liquid (231 mg, 70% yield). 1H NMR (400 MHz, CDCl3) δ 7.66 (dd,
J = 7.4, 2.1 Hz, 1H), 7.35 (dd, J = 7.2, 2.1 Hz, 1H), 7.28−7.22 (m,
4H), 7.19 (td, J = 5.4, 2.5 Hz, 3H), 5.12 (q, J = 12.5 Hz, 2H), 4.71 (s,
1H), 2.61 (td, J = 7.1, 2.2 Hz, 2H), 2.52−2.44 (m, 2H), 1.77 (dt, J =
6.1, 3.1 Hz, 4H). 13C{1H} NMR (101 MHz, CDCl3) δ 171.0, 135.7,
134.8, 133.9, 130.1, 129.5, 129.0, 128.4 (2C), 128.0, 127.8 (2C),
127.1, 67.9, 66.5, 52.0 (2C), 23.4 (2C). HRMS (ESI-TOF) m/z: [M
+ H+] calcd for C19H21ClNO2 330.1255, found 330.1173.
Cyclohexyl 2-(2-Chlorophenyl)-2-(pyrrolidin-1-yl)acetate ( 12).
Purification with petroleum ether/EtOAc (9:1) as the eluent;
1
colorless liquid (222 mg, 69% yield), H NMR (400 MHz, CDCl3)
δ 7.75−7.70 (m, 1H), 7.35 (dd, J = 7.8, 1.4 Hz, 1H), 7.29−7.17 (m,
2H), 4.80 (tt, J = 8.4, 3.7 Hz, 1H), 4.63 (s, 1H), 2.72−2.62 (m, 2H),
2.56−2.47 (m, 2H), 1.84−1.75 (m, 5H), 1.72−1.60 (m, 2H), 1.47
(m, 3H), 1.30 (m, 4H). 13C{1H} NMR (101 MHz, CDCl3) δ 170.4,
135.2, 133.8, 130.0, 129.4, 128.9, 127.0, 73.0, 68.2, 52.1 (2C), 31.3,
31.0, 25.3, 23.4 (3C), 23.2. HRMS (ESI-TOF) m/z: [M + H+] calcd
for C18H25ClNO2 322.1568, found 322.1561.
Methyl 2-Phenyl-2-(pyrrolidin-1-yl)acetate ( 13). Purification
with petroleum ether/EtOAc (9:1) as the eluent; colorless liquid
1
(178 mg, 81% yield). H NMR (400 MHz, CDCl3) δ 7.39 (dd, J =
7.8, 1.6 Hz, 2H), 7.27−7.20 (m, 3H), 3.86 (s, 1H), 3.59 (s, 3H),
2.52−2.45 (m, 2H), 2.36 (dd, J = 10.5, 3.2 Hz, 2H), 1.72 (td, J = 9.8,
8.3, 5.1 Hz, 4H). 13C{1H} NMR (101 MHz, CDCl3) δ 172.0, 137.1,
128.4 (2C), 128.3 (2C), 128.2, 73.7, 52.4 (2C), 52.0, 23.2 (2C).
HRMS (ESI-TOF) m/z: [M + H+] calcd for C13H18NO2 220.1332,
found 220.1328.
Methyl 2-(2-Fluorophenyl)-2-(pyrrolidin-1-yl)acetate ( 14). Pu-
rification with petroleum ether/EtOAc (9:1) as the eluent; colorless
liquid (168 mg, 71% yield). 1H NMR (400 MHz, CDCl3) δ 7.60 (td, J
= 7.5, 1.7 Hz, 1H), 7.33−7.26 (m, 1H), 7.19−7.13 (m, 1H), 7.10−
7.03 (m, 1H), 4.50 (s, 1H), 3.71 (s, 3H), 2.63 (dt, J = 10.7, 5.3 Hz,
2H), 2.51 (dt, J = 7.9, 5.1 Hz, 2H), 1.85−1.77 (m, 4H). 13C{1H}
NMR (101 MHz, CDCl3) δ 171.6, 160.5 (d, J = 247.3 Hz), 130.0 (d,
J = 3.4 Hz), 129.6 (d, J = 8.3 Hz), 124.3 (d, J = 3.5 Hz), 123.9 (d, J =
13.4 Hz), 115.5 (d, J = 22.5 Hz), 64.0, 52.1, 51.9 (2C), 23.3 (2C).
HRMS (ESI-TOF) m/z: [M + H+] calcd for C13H17FNO2 238.1238,
found 238.1235.
Methyl 2-(4-Chlorophenyl)-2-(pyrrolidin-1-yl)acetate ( 15). Pu-
rification with petroleum ether/EtOAc (9:1) as the eluent; colorless
liquid (216 mg, 85% yield). 1H NMR (400 MHz, CDCl3) δ 7.42 (d, J
= 8.5 Hz, 2H), 7.30 (d, J = 8.5 Hz, 2H), 3.90 (s, 1H), 3.68 (s, 3H),
2.58−2.50 (m, 2H), 2.46−2.38 (m, 2H), 1.80 (td, J = 5.7, 3.1 Hz,
4H). 13C{1H} NMR (101 MHz, CDCl3) δ 171.2, 135.8, 134.10 129.6
(2C), 128.7 (2C), 73.0, 52.4 (C), 52.1, 23.2 (2C). HRMS (ESI-TOF)
m/z: [M + H+] calcd for C13H17ClNO2 254.0942, found 254.0937.
Methyl 2-(4-Bromophenyl)-2-(pyrrolidin-1-yl)acetate ( 16). Pu-
rification with petroleum ether/EtOAc (9:1) as the eluent; colorless
liquid (246 mg, 83% yield). 1H NMR (400 MHz, CDCl3) δ 7.49 (d, J
= 8.5 Hz, 2H), 7.38 (d, J = 8.5 Hz, 2H), 3.91 (s, 1H), 3.70 (s, 3H),
Methyl 2-(3-Chlorophenyl)-2-(diethyl amino)acetate ( 21).
Purification with petroleum ether/EtOAc (9:1) as the eluent;
1
colorless liquid (208 mg, 81% yield). H NMR (400 MHz, CDCl3)
δ 7.49−7.45 (m, 1H), 7.35−7.26 (m, 3H), 4.48 (s, 1H), 3.74 (s, 3H),
2.62 (q, J = 7.1 Hz, 4H), 1.02 (t, J = 7.2 Hz, 6H). 13C{1H} NMR
(101 MHz, CDCl3) δ 172.2, 139.3, 134.3, 129.6, 128.7, 128.1, 126.8,
68.7, 51.8, 43.7 (2C), 12.0 (2C). HRMS (ESI-TOF) m/z: [M + H+]
calcd for C13H19ClNO2 256.1099, found 256.1096.
Methyl 2-(3-Chlorophenyl)-2-(piperidin-1-yl)acetate ( 22). Puri-
fication with petroleum ether/EtOAc (9:1) as the eluent; light-yellow
liquid (246 mg, 92% yield). 1H NMR (400 MHz, CDCl3) δ 7.46 (d, J
= 2.0 Hz, 1H), 7.34−7.30 (m, 1H), 7.30−7.23 (m, 2H), 3.96 (s, 1H),
3.69 (s, 3H), 2.37 (m, 4H), 1.59 (quin, J = 5.5 Hz, 4H), 1.43 (m, J =
6.0 Hz, 2H). 13C{1H} NMR (101 MHz, CDCl3) δ 171.6, 138.3,
134.3, 129.6, 128.7, 128.3, 126.8, 74.2, 52.2 (2C), 51.9, 25.7 (2C),
24.2. HRMS (ESI-TOF) m/z: [M + H+] calcd for C14H19ClNO2
268.1099, found 268.1104.
Methyl 2-(3-Chlorophenyl)-2-(4-hydroxypiperidin-1-yl)acetate
( 23). Purification with petroleum ether/EtOAc (7:3) as the eluent;
colorless liquid (222 mg, 78% yield). 1H NMR (400 MHz, CDCl3) δ
7.43 (s, 1H), 7.32−7.23 (m, 3H), 4.01 (s, 1H), 3.69 (s, 3H), 2.70
(ddt, J = 14.9, 9.1, 4.5 Hz, 2H), 2.30−2.20 (m, 1H), 2.19−2.10 (m,
1H), 2.06 (s, 1H), 1.93−1.82 (m, 2H), 1.62 (ddq, J = 18.7, 9.3, 5.8,
4.8 Hz, 2H). 13C{1H} NMR (101 MHz, CDCl3) δ 171.5, 138.1,
134.4, 129.7, 128.6, 128.4, 126.8, 73.3, 67.5, 52.0, 48.7, 48.5, 34.1
(2C). HRMS (ESI-TOF) m/z: [M + H+] calcd for C14H19ClNO3
284.1048, found 284.1044.
9687
J. Org. Chem. 2021, 86, 9682−9691